Loading clinical trials...

NMT EasyFit Sensor and Cable | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

NMT EasyFit Sensor and Cable

Evaluate Functionality and Use of the NMT EasyFit Sensor and NMT EasyFit Cable

NCT07394140•GE Healthcare

Summary

The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.

Detailed Description

The NMT Sensor provides quantitative, automated measurements of neuromuscular block by delivering non-invasive electrical stimuli to the ulnar nerve and recording electromyography (EMG) responses from the adductor pollicis muscle. Surface hydrogel electrodes with adhesive foam ensure secure placement for continuous monitoring. The single-use sensor connects to a reusable NMT Cable and is designed for use with GE HealthCare NMT measurement devices (NMT Module and bedside monitors).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Study subject (male or female) is age 18 years or older (≥18 years).
•2. Study subject must have the ability to understand and provide written informed consent.
•3. Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
•4. Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.

Exclusion Criteria

•1. Are known to be pregnant.
•2. Are breastfeeding.
•3. Suffering from an infection(s) that requires isolation.
•4. Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
•5. Subjects requiring rapid sequence induction
•6. Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.
•7. Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).
•8. NMT ElectroSensor placed on the foot/ankle

Locations (1)

Loma Linda University Health

Loma Linda, California, United States

Key Dates

Start Date

February 1, 2026

Primary Completion Date

May 31, 2026

Completion Date

December 31, 2026

Last Updated

February 6, 2026

Enrollment

ESTIMATED participants

Conditions

Neuromuscular Blockade MonitoringNeuromuscular Monitoring After Administration of Neuromuscular Blocking Agents in Different Types of Surgery

Interventions

NMT Technology

DEVICE

Contacts

Melissa McCabe, MD

CONTACT

909-558-4475 mmccabe@llu.edu

Morgan Blazy

CONTACT

909-558-4256 Mblazy@llu.edu

Estimation of Neuromuscular Recovery - a Validation Study

NCT05716282

Neuromuscular Blockade Monitoring

View study

ENROLLING_BY_INVITATIONPHASE4

Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis

NCT07080528

Neuromuscular Blocking AgentsResidual Neuromuscular Block+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 6, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

NMT EasyFit Sensor and Cable

Inclusion Criteria

Exclusion Criteria

Estimation of Neuromuscular Recovery - a Validation Study

Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis

Effects of Low-pressure Pneumoperitoneum Associated With Deep Pipecuronium-induced Neuromuscular Blockade on Hemodynamic Parameters for High Cardiovascular Risk Patient Undergoing General Anesthesia

Observational Study to Evaluate the Current Neuromuscular Monitoring Practice Used After Different Types of Surgery, for Which Neuromuscular Blocking Agents Were Used, With or Without Blocking Reversal (P06556)